Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, India.
Curr Pharm Biotechnol. 2021;22(11):1466-1481. doi: 10.2174/1389201021666201218130947.
Stem cell therapy efficiently targets the brain for most neurological disorders like migraine, Parkinsonism, schizophrenia, Alzheimer's disease, and brain injury. The major obstacles in potential brain targeting are the physiological barriers like blood-brain-barrier and bloodcerebrospinal fluid barrier. The conventional injectable route or direct transplantation of stem cells results in brain injury and is less feasible clinically. The alternative to these invasive routes is the intranasal route that is non-invasive, easily repeatable technique and highly effective in brain targeting without crossing the blood-brain barrier. Extensive research has been undertaken for the delivery of stem cells to the brain via the intranasal route that holds great potential in overcoming the existing barriers. Nanotechnology is emerging as a novel interdisciplinary field in the arena of stem cell research. The combination of nanotechnology coupled with stem cell therapy has led to synergistic outcomes in diagnostic and therapeutic applications of neurological diseases. This review provides insights into stem cell-based nanotherapy for brain targeting via the intranasal route.
干细胞疗法有效地针对大多数神经疾病(如偏头痛、帕金森病、精神分裂症、阿尔茨海默病和脑损伤)的大脑。潜在的脑靶向的主要障碍是血脑屏障和血脑脊液屏障等生理屏障。传统的注射途径或直接移植干细胞会导致脑损伤,在临床上不太可行。这些侵入性途径的替代方法是鼻内途径,它是非侵入性的,易于重复的技术,并且在不穿过血脑屏障的情况下对大脑靶向非常有效。已经进行了大量研究,通过鼻内途径将干细胞递送到大脑,这在克服现有障碍方面具有巨大潜力。纳米技术作为干细胞研究领域的一个新的跨学科领域正在兴起。纳米技术与干细胞疗法的结合在神经疾病的诊断和治疗应用中产生了协同作用。本文综述了通过鼻内途径进行脑靶向的基于干细胞的纳米治疗。